Stock market is an attractive way to grow your money. But, a wrong investment can prove counter-productive and lead to losses. This is why it is important to identify the right product. Buoyed by revenue growth higher than expected, equity experts are bullish on Dishman Carbogen Amics stock. According to the experts, the stock can give whopping 70 per cent gains in the scrip in long-term perspective -- in one and half to two years.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

It means an investor can expect his Rs 1,000 investment to become Rs 1,700 in a mere two year time, say experts.

Speaking on the outlook of the strip Amey Chalke, Analyst at HDFC Securities told Zee Business online, "While Dishman’s (DCAL) 3Q performance was ahead of our estimates, revenue growth was muted as a large chunk of orders was shifted over to fourth quarter.

Despite revenue growth being limited to 4/7 per cent YoY/QoQ, a shift in business mix towards high-margin segments (CRAMS India and Vitamin D) led to a 750bps YoY expansion in gross margin (up to 85 per cent in 3Q) and a 10 per cent YoY growth in EBITDA (despite higher opex), with margin at 27.7 per cent (+136bps YoY).

Lower tax rate at 31 per cent further boosted PAT, which stood at Rs 514mn, up 22/17 per cent YoY/QoQ.

Having achieved Rs 14.1bn revenues and 27.1 per cent EBITDA margin (+800bps YoY) in 9MFY19, we expect DCAL to deliver 13 per cent plus rev. growth and 27.5 per cent plus margin for FY19 post a bumper 4Q." He said that till date, DCAL’s partners have filed 5-6 products with the regulatory authorities, which makes it likely to receive at least 2 approvals each year over FY20-22."

Watch This Zee Business Video

On what he suggest market investors in regard to Dishman Carbogen Amics outlook Amey Chalke of HDFC Securities told, "We recommend investors to buy the strip for a target of Rs 380 per shares levels in long-term perspective."

Currently the stock is priced in the range of Rs 222, means an investor can expect around 70 per cent growth on his investment in long-term.